Jefferies Financial Group Inc. Celldex Therapeutics, Inc. Transaction History
Jefferies Financial Group Inc.
- $15.9 Billion
- Q4 2024
A detailed history of Jefferies Financial Group Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 2,390,398 shares of CLDX stock, worth $43.7 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,390,398
Previous 2,390,398
-0.0%
Holding current value
$43.7 Million
Previous $60.4 Million
-0.0%
% of portfolio
0.38%
Previous 0.38%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
199Shares Held
60.8MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$92.7 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$85.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$71 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$68.7 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$65.1 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $856M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...